Platform combines document extraction, specialistlinguistic review, and automated layout reconstruction to simplify adverseevent case translation.
NEW YORK,October 14, 2026 — Welo Life Sciences, a WeloGlobal brand, today announced Glass PV,an AI-enabled pharmacovigilance case translation platform. Glass PV turns scanned adverse event documents, includinghandwritten notes, mixed languages, and complex layouts, into translated PDFs intheir structure at scale
According to WelocalizeLife Sciences’ measurements across completed cases, close to 100% of casesare delivered within the required 12- or 24-hour regulatory window. Theplatform uses an all-inclusive, per-case pricing model to give customersgreater cost predictability without separate translation, formatting, orproject management fees.
Glass PVaddresses a persistent challenge in pharmacovigilance: scanned safety casedocuments that contain handwritten notes, multiple languages, and complexlayouts are hard to process at scale and speed. Thesedocuments can require manual transcription and coordination among translators,desktop publishing specialists, and project managers.
Glass PV brings document intake, text extraction, expertreview, translation, and layout reconstruction into a single AI-enabled workflow.Specialist linguists trained in safety narratives, case terminology, andadverse event reporting review the translation.
“Safety teamsare working against regulatory clocks. They shouldn't need four people and achain of emails to efficiently translate one scanned case with handwriting onthe page,” said Cristina Pardo, General Manager of Welo Life Sciences. “Glass PVeliminates manual handoffs. You submit the case, and you get back a translateddocument with the layout intact.”
Glass PVmaintains an audit trail of document changes and review decisions to supporttraceability, with enterprise single sign-on and role-based access controls tomanage access. Data is processed within Welo Life Sciences’ secure infrastructureunder a data processing agreement. The platform also provides configurableaccount workflows and supports translation in more than 300 languages.
“We put ourname on the clock and on the quality,” Pardo added. “Automation handlesextraction and layout, specialist linguists who know safety narratives own thelanguage, and every edit and decision is recorded. Any translation can bereopened and reviewed, and that is what accountability looks like in this space.”
For moreinformation or to request a Glass PV demonstration, visit welolifesciences.comor contact [email protected].
AboutWelo Life Sciences
Welo LifeSciences, a Welo Global brand, is a specialized language and technology partnerserving pharmaceutical, CRO, and medical device organizations operating inregulated global markets. We deliver regulator-ready translation, linguisticvalidation, and localization solutions that support clinical trials,pharmacovigilance, regulatory affairs, labeling, and global commercialization.Our approach combines subject matter expertise with ISO-certified qualityprocesses and technology-enabled workflows designed to integrate seamlesslyinto life sciences operations. With extensive experience supporting globalproduct development and post-market requirements, Welo Life Sciences helpsorganizations accelerate timelines, protect data integrity, and maintaincompliance across languages and regions. All solutions are delivered within asecure, audit-ready framework supported by seven ISO certifications. welolifesciences.com
Media contact: [email protected]